Literature DB >> 11853547

Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.

Jason Perret1, Mélanie Van Craenenbroeck, Ingrid Langer, Pascale Vertongen, Françoise Gregoire, Patrick Robberecht, Magali Waelbroeck.   

Abstract

Receptor recognition by the Asp(3) residues of vasoactive intestinal peptide and secretin requires the presence of a lysine residue close to the second transmembrane helix (TM2)/first extracellular loop junction and an ionic bond with an arginine residue in TM2. We tested whether the glucagon Gln(3) residue recognizes the equivalent positions in its receptor. Our data revealed that the binding and functional properties of the wild-type glucagon receptor and the K188R mutant were not significantly different, whereas all agonists had markedly lower potencies and affinities at the I195K mutated receptor. In contrast, glucagon was less potent and the Asp(3)-, Asn(3)- and Glu(3)-glucagon mutants were more potent and efficient at the double-mutated K188R/I195K receptor. Furthermore, these alterations were selective for position 3 of glucagon, as shown by the functional properties of the mutant Glu(9)- and Lys(15)-glucagon. Our results suggest that although the Gln(3) residue of glucagon did not interact with the equivalent binding pocket as the Asp(3) residue of vasoactive intestinal peptide or secretin, the Asp(3)-glucagon analogue was able to interact with position 188 of the K188R/I195K glucagon receptor. Nevertheless, the Gln(3) side chain of glucagon probably binds very close to this region in the wild-type receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853547      PMCID: PMC1222399          DOI: 10.1042/0264-6021:3620389

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  X-ray analysis of glucagon and its relationship to receptor binding.

Authors:  K Sasaki; S Dockerill; D A Adamiak; I J Tickle; T Blundell
Journal:  Nature       Date:  1975-10-30       Impact factor: 49.962

2.  Structure-function relationships in glucagon: properties of highly purified des-His-1-, monoiodo-, and (des-Asn-28, Thr-29)(homoserine lactone-27)-glucagon.

Authors:  M C Lin; D E Wright; V J Hruby; M Rodbell
Journal:  Biochemistry       Date:  1975-04-22       Impact factor: 3.162

3.  A cDNA construct allowing the expression of rat hepatic glucagon receptors.

Authors:  M Svoboda; E Ciccarelli; M Tastenoy; P Robberecht; J Christophe
Journal:  Biochem Biophys Res Commun       Date:  1993-04-15       Impact factor: 3.575

4.  Structure of glucagon-like peptide (7-36) amide in a dodecylphosphocholine micelle as determined by 2D NMR.

Authors:  K Thornton; D G Gorenstein
Journal:  Biochemistry       Date:  1994-03-29       Impact factor: 3.162

5.  1H nuclear-magnetic-resonance studies of the molecular conformation of monomeric glucagon in aqueous solution.

Authors:  C Boesch; A Bundi; M Oppliger; K Wüthrich
Journal:  Eur J Biochem       Date:  1978-11-02

6.  Glucagon antagonists. Synthesis and inhibitory properties of Asp3-containing glucagon analogs.

Authors:  D Andreu; R B Merrifield
Journal:  Eur J Biochem       Date:  1987-05-04

7.  Selective stabilization of the high affinity binding conformation of glucagon receptor by the long splice variant of Galpha(s).

Authors:  C G Unson; C R Wu; T P Sakmar; R B Merrifield
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

8.  Position 9 replacement analogs of glucagon uncouple biological activity and receptor binding.

Authors:  C G Unson; D Macdonald; K Ray; T L Durrah; R B Merrifield
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

9.  Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis.

Authors:  M O'Donnell; R J Garippa; N Rinaldi; W M Selig; J E Tocker; S A Tannu; M A Wasserman; A Welton; D R Bolin
Journal:  J Pharmacol Exp Ther       Date:  1994-09       Impact factor: 4.030

10.  Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes.

Authors:  S A Hjorth; K Adelhorst; B B Pedersen; O Kirk; T W Schwartz
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

View more
  14 in total

1.  Mutational and cysteine scanning analysis of the glucagon receptor N-terminal domain.

Authors:  Martine Prévost; Pascale Vertongen; Vincent Raussens; David Jonathan Roberts; Johnny Cnudde; Jason Perret; Magali Waelbroeck
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

Review 2.  Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.

Authors:  M Dong; C Koole; D Wootten; P M Sexton; L J Miller
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 3.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

4.  Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).

Authors:  Dehua Yang; Chris de Graaf; Linlin Yang; Gaojie Song; Antao Dai; Xiaoqing Cai; Yang Feng; Steffen Reedtz-Runge; Michael A Hanson; Huaiyu Yang; Hualiang Jiang; Raymond C Stevens; Ming-Wei Wang
Journal:  J Biol Chem       Date:  2016-04-08       Impact factor: 5.157

5.  Ligand binding pocket formed by evolutionarily conserved residues in the glucagon-like peptide-1 (GLP-1) receptor core domain.

Authors:  Mi Jin Moon; Yoo-Na Lee; Sumi Park; Arfaxad Reyes-Alcaraz; Jong-Ik Hwang; Robert Peter Millar; Han Choe; Jae Young Seong
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 6.  Insights into the structure of class B GPCRs.

Authors:  Kaspar Hollenstein; Chris de Graaf; Andrea Bortolato; Ming-Wei Wang; Fiona H Marshall; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2013-12-18       Impact factor: 14.819

7.  Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.

Authors:  S Runge; B S Wulff; K Madsen; H Bräuner-Osborne; L B Knudsen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.

Authors:  Maoqing Dong; Polo C-H Lam; Andrew Orry; Patrick M Sexton; Arthur Christopoulos; Ruben Abagyan; Laurence J Miller
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

9.  Structure of the human glucagon class B G-protein-coupled receptor.

Authors:  Fai Yiu Siu; Min He; Chris de Graaf; Gye Won Han; Dehua Yang; Zhiyun Zhang; Caihong Zhou; Qingping Xu; Daniel Wacker; Jeremiah S Joseph; Wei Liu; Jesper Lau; Vadim Cherezov; Vsevolod Katritch; Ming-Wei Wang; Raymond C Stevens
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

10.  Origin of secretin receptor precedes the advent of tetrapoda: evidence on the separated origins of secretin and orexin.

Authors:  Janice K V Tam; Kwan-Wa Lau; Leo T O Lee; Jessica Y S Chu; Kwong-Man Ng; Alain Fournier; Hubert Vaudry; Billy K C Chow
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.